R&G PharmaStudies Co., Ltd. (SHE:301333)
China · Delayed Price · Currency is CNY 66.67
+0.68 (1.03%)
At close: Sep 23, 2026
R&G PharmaStudies Market Cap
R&G PharmaStudies has a market cap or net worth of 6.32 billion as of September 23, 2026. Its market cap has increased by 20.09% in one year.
Market Cap
6.32B
Enterprise Value
4.67B
Revenue
939.31M
Ranking
n/a
PE Ratio
52.86
Stock Price
66.67
ChartMarket Cap Chart
Since August 2, 2022, R&G PharmaStudies's market cap has increased from 5.40B to 6.32B, an increase of 17.05%. That is a compound annual growth rate of 3.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 6.39B | 12.73% |
| Dec 31, 2025 | 5.67B | 19.12% |
| Dec 31, 2024 | 4.76B | -23.17% |
| Dec 29, 2023 | 6.19B | 25.30% |
| Dec 30, 2022 | 4.94B | -8.52% |
| Aug 2, 2022 | 5.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding